FCM
Frontier Capital Management Portfolio holdings
AUM
$10.8B
1-Year Return
32.36%
This Quarter Return
+6.87%
1 Year Return
+32.36%
3 Year Return
+147.77%
5 Year Return
+285.35%
10 Year Return
+891.74%
AUM
$13.9B
AUM Growth
+$169M
(+1.2%)
Cap. Flow
-$581M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
12.22%
Holding
337
New
15
Increased
131
Reduced
163
Closed
16
Top Buys
| 1 |
SS&C Technologies
SSNC
|
$64.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$57.6M |
| 3 |
MACOM Technology Solutions
MTSI
|
$57.3M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
$54.2M |
| 5 |
CAVM
Cavium, Inc.
CAVM
|
$46.2M |
Top Sells
| 1 |
Equifax
EFX
|
$146M |
| 2 |
Boise Cascade
BCC
|
$75.4M |
| 3 |
Cogent Communications
CCOI
|
$58.7M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$58M |
| 5 |
Cooper Companies
COO
|
$51.2M |
Sector Composition
| 1 | Technology | 20.06% |
| 2 | Industrials | 17.33% |
| 3 | Financials | 12.9% |
| 4 | Healthcare | 12.9% |
| 5 | Consumer Discretionary | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Eastman Chemical
EMN
$7.88B
| $29K | ﹤0.01% |
317
| – | – |
|
|
MFA
302
MFA Financial
MFA
$1.07B
| $27K | ﹤0.01% |
759
-68
| -8% | -$2.42K |
|
303
Labcorp
LH
$23B
| $26K | ﹤0.01% |
200
-19
| -9% | -$2.47K |
|
|
NBL
304
DELISTED
Noble Energy, Inc.
NBL
| $26K | ﹤0.01% |
922
+103
| +13% | +$2.91K |
|
|
QVCGA
305
QVC Group, Inc. Series A Common Stock
QVCGA
$70.8M
| $25K | ﹤0.01% |
22
| – | – |
|
|
COL
306
DELISTED
Rockwell Collins
COL
| $25K | ﹤0.01% |
195
-125
| -39% | -$16K |
|
307
Boston Scientific
BSX
$158B
| $24K | ﹤0.01% |
807
| – | – |
|
308
Fidelity National Financial
FNF
$16.4B
| $24K | ﹤0.01% |
740
| – | – |
|
309
Keysight
KEYS
$28.6B
| $22K | ﹤0.01% |
536
| – | – |
|
310
Trane Technologies
TT
$91.2B
| $22K | ﹤0.01% |
242
-25
| -9% | -$2.27K |
|
311
Western Digital
WDC
$31.9B
| $21K | ﹤0.01% |
320
-151
| -32% | -$9.91K |
|
312
Ralph Lauren
RL
$18.9B
| $20K | ﹤0.01% |
224
+26
| +13% | +$2.32K |
|
|
CSRA
313
DELISTED
CSRA Inc.
CSRA
| $20K | ﹤0.01% |
634
+72
| +13% | +$2.27K |
|
314
Allison Transmission
ALSN
$7.46B
| $19K | ﹤0.01% |
498
-200
| -29% | -$7.63K |
|
315
DaVita
DVA
$9.85B
| $19K | ﹤0.01% |
327
| – | – |
|
316
Jones Lang LaSalle
JLL
$14.7B
| $19K | ﹤0.01% |
151
| – | – |
|
317
Northern Trust
NTRS
$24.1B
| $18K | ﹤0.01% |
198
| – | – |
|
318
Micron Technology
MU
$143B
| $16K | ﹤0.01% |
403
-650
| -62% | -$25.8K |
|
319
Methanex
MEOH
$2.95B
| $15K | ﹤0.01% |
293
-77
| -21% | -$3.94K |
|
320
Designer Brands
DBI
$230M
| $14K | ﹤0.01% |
660
| – | – |
|
321
Pediatrix Medical
MD
$1.47B
| $7K | ﹤0.01% |
172
| – | – |
|
|
AZUL
322
DELISTED
Azul
AZUL
| – | – |
-6,056
| Closed | -$128K |
|
|
323
Equifax
EFX
$30.8B
| – | – |
-1,062,286
| Closed | -$146M |
|
324
Kohl's
KSS
$1.85B
| – | – |
-328
| Closed | -$13K |
|
325
Pacira BioSciences
PCRX
$1.19B
| – | – |
-123,857
| Closed | -$5.91M |
|